Global OTC Analgesics Review - Nicholas Hall & Company

Nicholas Hall’s
Global OTC
Analgesics Review
With full-year sales data to end-2009
and MAT to mid-2010 topline sales from DB6 2010
A Global Category Review from Nicholas Hall & Company

Global OTC Analgesics Review
The odds are against analgesics: safety concerns over key ingredients,
the recessionary environment and strong generic competition all stand
in the way of growth. Despite this, the mature analgesics market soared
to new heights in 2009-10, with all leading brands registering a positive
CAGR since 2005.
Systemic presentations continue to dominate in terms of sales and growth,
with premium-priced topical brands struggling in some countries where
cash-strapped consumers are turning to value offerings. Oral pain
remains underdeveloped in most regions, but new medical device
treatments for mouth ulcers show potential to expand the category.
Along with umbrella branding, value through segmentation is a key route
to success, with marketers expanding and launching brands into
niche areas such as migraine and foot pain. Rx-to-OTC switches provide
momentum, with marketers quick to take advantage of beneficial
regulations. This does not mean that well-established ingredients are
forgotten: marketers successfully differentiate their brands from
generic offerings through innovative delivery formats, with fast-acting
claims popular.
This report will examine in depth how the analgesics market achieved
strong growth despite the odds, exploring the core strategies of
leading OTC marketers and investigating how top brands stayed at the
top. It will also look beyond, providing an overview of potential switches
and charting routes to further growth.
Nicholas Hall

CONTENTS
Executive Summary
Overview of the major trends, developments and
consumer preferences
Analysis of the leading analgesics marketers
Analysis of Analgesics Markets by Region
North America: Canada USA
Western Europe: France Germany Italy Spain UK
Central & Eastern Europe: Poland Russia
Asia-Pacific: Australia China India Japan S Korea
Latin America: Brazil Mexico
(Major trends / developments in other key markets in each
region will also be covered)
Each country profile contains a detailed overview,
key growth drivers, regulatory issues, switches, A+P and
prospects for the future. Charts cover 2005-09 sales
(plus MAT to mid-2010), growth rate analysis, leading
marketers, top brands, legal status of key ingredients,
categories segmented by ingredient, and forecasts.
Brand Case Studies
Profiles of 12 key analgesic brands, with sales data, strategic
analysis and success factors for each:
Advil Aleve Baiyao Doliprane Eve Fenbid
Nurofen Panadol Pentalgin-Pharmstandart
Tylenol Voltaren Zandu Balm
Exploring Niche Positioning
Assessment of the potential in various niches (including
migraine, menstrual pain, mouth ulcers, arthritis), as
marketers increasingly look to ways of segmenting the
analgesics market to boost sales.
Global Outlook for Analgesics
Analysis of the global market’s future performance
Sales forecasts to 2014 and 2019
Switch pipeline Nicholas Hall’s Strategies for Success
Analgesics categories covered include:
Systemic analgesics Topical analgesics
Oral pain relievers Crossover into adjacent categories
(cold & flu, glucosamine, medical devices, etc.)
The report contains full-year sales data to the end of 2009,
plus topline sales for the 12 months to mid-2010, from DB6.

Please tick as appropriate:
I would like to order the global licence for the complete report at £12,000
I would like to order the country-only licence for the complete report
at £9,000
N.B. A global licence will be required if you wish to place this report on your
company’s intranet. All prices quoted in British pounds sterling.
A cheque is enclosed / follows under separate cover for £
(Please make cheques payable to Nicholas Hall & Company)
Please invoice my company quoting the ref. / order no.
I would like to make payment by credit card. Please debit my:
Visa Master Card American Express Other
Card no:
Expiry date: Security code (not needed for Amex)
Please tick if you do not wish to be included in future mail fax
email campaigns
Nicholas Hall & Company
35 Alexandra Street, Southend-on-Sea, Essex SS1 1BW
T: +44 (0)1702 220 200 F: +44 (0)1702 430 787
E: info@NicholasHall.com W: www.NicholasHall.com
✂ PAYMENT DETAILS
NICHOLAS HALL’S GLOBAL
OTC ANALGESICS REVIEW
ORDER FORM FAX BACK TO +44 (0)1702 220 241
If you do not wish to purchase the entire report, we can provide individual
category chapters or selected country coverage at a discounted rate.
For further information on this, please email us at: info@NicholasHall.com
DELIVERY DETAILS
Title: Mr / Mrs / Ms / Dr First name
Surname
Job title
Company
Address
City Postcode
Country
Tel: Fax:
E-mail:
Signed Date

Nicholas Hall’s
Global
OTC Analgesics
Review
Published in PowerPoint
on CD-ROM
● Easy access
● Quick delivery
● Versatile format
●
Full-year sales data to
end-2009 and MAT to mid-2010
topline sales from DB6 2010
●
Available as a complete report,
and by individual category
chapters or selected
country coverage
●
5% discount for payment
by credit card

Nicholas Hall & Company offers the
world’s most complete
OTC marketing support service
DEFINITIVE REPORTS
A wide range of authoritative reports and special studies by internationally respected authors provide in-depth information,
analysis and guidance for strategic planning.
DEDICATED OTC GLOBAL DATABASE
Nicholas Hall’s unique DB6 database goes far beyond traditional audit data to provide market intelligence, analysis and
insight. It complements Nicholas Hall reports to give you the platform for effective planning – allowing you to create your
own reports from over 120,000 pieces of stored information. DB6 is available online and in disk format, enabling it to be
used while “on the move”.
Nielsen has licensed its entire OTC market data to Nicholas Hall & Company, resulting in a substantially enhanced
DB6 database. Nielsen measures around half the gobal market by value, and this gives DB6 added strength in a
number of important countries and categories, especially VMS.
CONFERENCES AND ACTION WORKSHOPS
Nicholas Hall’s programme of conferences and action workshops picks up on the topical questions of the day – broadening
understanding by sharing experiences.
CONSULTANCY AND PRODUCT BROKERAGE
Nicholas Hall provides confidential strategic advice and purpose-designed solutions to specific challenges, working across
the globe with local, regional and multinational companies large and small. We also offer a dedicated OTC product
brokerage service, helping marketers to achieve wider distribution speedily and cost-effectively.
Nicholas Hall’s INSIGHT
Five editions cover the world’s OTC markets: Western Europe, Central & Eastern Europe, North America, Latin America
and Asia-Pacific. They evaluate the OTC market by category, company, brand and geographic area, to show all the latest
developments both nationally and internationally. Nicholas Hall’s Insight Online offers the latest editions of
all five publications plus a searchable archive, electronically at the click of a button.
OTC.Newsflash
A subscription-only service that gives you exclusive access to the OTC.Newsflash website and its treasure house
of information and news, which has built up weekly over the ten years since its September 2000 launch to become the
OTC industry’s most comprehensive archive. It keeps you and your company informed about the world of OTC but
without information overload.
It provides vital background information and gives essential insight, with a host of other features. At the same time it
is concise, accessible and easy to use. Subscribers receive our much-loved weekly email news bulletin, with the usual mix
of news, editorial comments and insight, and our own brand of quirky humour, direct to their desktop each week.
Please contact us direct for further information.
For more details visit www.NicholasHall.com – or email info@NicholasHall.com
Nicholas Hall & Company
35 Alexandra Street,
Southend-on-Sea, Essex SS1 1BW, UK
T: +44 (0) 1702 220 200 F: +44 (0) 1702 430 787
E: info@NicholasHall.com W: www.NicholasHall.com